INS and type 1 diabetes mellitus: Foltynski et al. evaluated the efficacy of such a system (VoiceDiab) in controlling postprandial blood glucose concentrations in persons with type 1 diabetes treated with a continuous, subcutaneous insulin infusion under ambulatory conditions [18].